Fabrication and in vitro evaluation of bidirectional release and stability studies of mucoadhesive donut-shaped captopril tablets

Drug Development and Industrial Pharmacy

Volumn 38, Issue 6, 2012, Pages 706-717

  Mandal, Asim Sattwa ^a   Chatterjee, Sugata ^a   Karim, Kazi Masud ^a   Biswas, Nikhil ^a   Guha, Arijit ^a   Behera, Mamata ^a   Kuotsu, Ketousetuo ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Captopril; Coating; Donut shaped; Mucoadhesive; Tablet

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYPROPYLMETHYLCELLULOSE; STEARIC ACID; TALC; WATER;

ADHESION; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED DRUG RELEASE; DRUG COATING; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ESSENTIAL HYPERTENSION; EX VIVO STUDY; FILM; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; IN VITRO STUDY; INFRARED SPECTROSCOPY; PH; STOMACH; TABLET FORMULATION; TENSILE STRENGTH;

ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; CARBOXYMETHYLCELLULOSE SODIUM; DELAYED-ACTION PREPARATIONS; POLYMERS; SOLUBILITY; TABLETS; TENSILE STRENGTH; WATER;

EID: 84860387937     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.623167     Document Type: Article

References (23)

1. El-Kamel AH, Al-Shora DH, El-Sayed YM. (2006). Formulation and pharmacodynamic evaluation of captopril sustained release microparticles. J Microencapsul, 23:389-404. (Pubitemid 44132548)
2. Seta Y, Higuchi F, Kawahara Y, Nishimura K, Okada R. (1988). Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties. Int J Pharm, 41:245-254. (Pubitemid 18034878)
3. Chen D, Chen H, Ku H. (1995). Degradation rates of captopril in aqueous medium through buffer-catalysis oxidation. Drug Dev Ind Pharm, 21:781-792.
4. Hillaert S, Van den Bossche W. (1999). Determination of captopril and its degradation products by capillary electrophoresis. J Pharm Biomed Anal, 21:65-73. (Pubitemid 29430143)
5. Higuchi WI. (1962). Analysis of data on the medicament release from ointments. J Pharm Sci, 51:353-357.
6. Roseman RW, Higuchi WI. (1970). Release of medroxyprogesterone acetate from a silicone polymer. J Pharm Sci, 17:698-602.
7. Kim CJ. (1999). Release kinetics of coated, donut-shaped tablets for water soluble drugs. Eur J Pharm Sci, 7:237-242.
8. Banker GS, Anderson N. (1987). Tablets. In: Lachman L., Lieberman HA, Kanig JL, eds. The Theory and Practice of Industrial Pharmacy. Bombay 400014, India: Varghese Publishing House, 293-294.
9. Kim CJ. (2005). Controlled release from triple layer, donut-shaped tablets with enteric polymers. AAPS PharmSciTech, 6:E429-E436.
10. Cheng K, Zhu J, Song X, Sun L, Zhang J. (1999). Studies of hydroxypropyl methylcellulose donut-shaped tablets. Drug Dev Ind Pharm, 25:1067-1071. (Pubitemid 29457938)
11. Jantzen GM, Robinson JR. Sustained and controlled release drug delivery systems. In: Banker GS, Rhodes CT, eds. Modern Pharmaceutics. 270 Madison Avenue, New York, NY 10016: Marcel Dekker, Inc., fourth ed., chap 15.
12. Rajput GC, Majmudar FD, Patel JK, Thakor RS, Patel BP, Rajgor NB. (2010). Stomach specific mucoadhesive tablets as controlled drug delivery system-A review work. International J Pharm Biological Research, 1:30-41.
13. Davis SS. (2005). Formulation strategies for absorption windows. Drug Discov Today, 10:249-257. (Pubitemid 40222218)
14. http://www.txt.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070124.pdf
15. Hogan JE. (1995). Film-coating materials and their properties. In: Cole G, ed. Pharmaceutical Coating Technology. 1900 Frost Road, Suite 101, Bristol, PA 19007: Taylor & Francis Inc., 7-49.
16. Bussemer T, Peppas NA, Bodmeier R. (2003). Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm Biopharm, 56:261-270. (Pubitemid 37072111)
17. Tobyn MJ, Johnson JR, Dettmar PW. (1997). Factors affecting in vitro gastric mucoadhesion IV. Influence of tablet excipients, surfactants and salts on the observed mucoadhesion of polymers. Eur J Pharm Biopharm, 43:65-71. (Pubitemid 28298812)
18. Ahuja A, Khar RK, Ali J. (1997). Mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 23:489-415.
19. Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. (2008). Polymers for mucoadhesive drug delivery system: a current status. Drug Dev Ind Pharm, 34:1246-1266.
20. Hagesaether E, Hiorth M, Sande SA. (2009). Mucoadhesion and drug permeability of free mixed films of pectin and chitosan: an in vitro and ex vivo study. Eur J Pharm Biopharm, 71: 325-331.
21. Smart JD. (2005). The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev, 57:1556-1568. (Pubitemid 41443469)
22. Lehr CM, Bowstra JA, Tukker JJ, Junginger HE. (1990). Intestinal transit of bioadhesive microspheres in an in situ loop in the rat-A comparative study with copolymers and blends based on poly(acrylic acid). J Control Release, 13:51-62. (Pubitemid 20221201)
23. http://www.txtfda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070237.pdsf